Brighton Jones’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$360K Buy
9,843
+124
+1% +$4.5K 0.01% 965
2026
Q2
$344K Sell
9,719
-722
-7% -$21.3K 0.01% 979
2026
Q1
$289K Buy
+10,441
New +$268K 0.01% 950

Other funds holding ROIV

Brighton Jones's ROIV Position: Q3 2026 in Review

Brighton Jones increased its Roivant Sciences (ROIV) stake by 1.3% in Q3 2026, buying an estimated $4.5K and bringing the position to 9,843 shares worth $360K. The position accounts for 0.01% of the portfolio, ranked #965.

Brighton Jones first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 409 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Brighton Jones held 9,843 shares of Roivant Sciences worth $360K as of Q3 2026.
  • Brighton Jones bought 124 Roivant Sciences shares in Q3 2026, an estimated $4.5K.
  • Roivant Sciences made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #965 holding.
  • Brighton Jones first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
  • 409 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.